S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
World-Renowned Brazilian Restaurant Debuts in Canada (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
The Graphite Shortage Story You're Not Being Told (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What is the Penalty for Excess Contributions to an IRA?
Is Graphite the New Lithium? (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
World-Renowned Brazilian Restaurant Debuts in Canada (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
The Graphite Shortage Story You're Not Being Told (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What is the Penalty for Excess Contributions to an IRA?
Is Graphite the New Lithium? (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
World-Renowned Brazilian Restaurant Debuts in Canada (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
The Graphite Shortage Story You're Not Being Told (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What is the Penalty for Excess Contributions to an IRA?
Is Graphite the New Lithium? (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
World-Renowned Brazilian Restaurant Debuts in Canada (Ad)
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Nordstrom's Earnings Beat, A Rally In The Making
The Graphite Shortage Story You're Not Being Told (Ad)
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
What is the Penalty for Excess Contributions to an IRA?
Is Graphite the New Lithium? (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
NASDAQ:MDVL

MedAvail (MDVL) Stock Forecast, Price & News

$0.28
+0.04 (+16.67%)
(As of 06/1/2023 ET)
Compare
Today's Range
$0.24
$0.32
50-Day Range
$0.17
$0.33
52-Week Range
$0.10
$1.82
Volume
258,882 shs
Average Volume
75,908 shs
Market Capitalization
$22.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

MedAvail MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
971.8% Upside
$3.00 Price Target
Short Interest
Healthy
0.35% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$32,725 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.30) to ($0.13) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.48 out of 5 stars

Medical Sector

1775th out of 1,980 stocks

Drug Stores & Proprietary Stores Industry

7th out of 12 stocks


MDVL stock logo

About MedAvail (NASDAQ:MDVL) Stock

MedAvail Holdings, Inc. is a pharmacy technology and services company, which engages in the development and commercialization of a self-service pharmacy, mobile application, and kiosk. It operates through the Retail Pharmacy Services and Pharmacy Technology segments. The Retail Pharmacy Services segment includes MedAvail Pharmacy Inc. and does business under the trade name SpotRx Pharmacy. The Pharmacy Technology segment represents MedAvail Technologies Inc. that sells the system including MedCenter prescription dispensing kiosk, software, integration, and maintenance services. The company was founded on April 11, 2007 and is headquartered in Phoenix, AZ.

Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

MDVL Stock News Headlines

The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
8-K: MedAvail Holdings, Inc.
MedAvail Holdings's Earnings: A Preview
What Wall Street expects from MedAvail's earnings
MedAvail (MDVL) Scheduled to Post Earnings on Thursday
MedAvail Reports Third Quarter 2022 Financial Results
MDVL MedAvail Holdings, Inc.
See More Headlines

MDVL Price History

MDVL Company Calendar

Last Earnings
11/08/2021
Today
6/01/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MDVL
Employees
287
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+971.8%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-47,620,000.00
Net Margins
-150.00%
Pretax Margin
-157.41%

Debt

Sales & Book Value

Annual Sales
$43.11 million
Book Value
$0.05 per share

Miscellaneous

Free Float
77,545,000
Market Cap
$22.54 million
Optionable
Not Optionable
Beta
0.38

Key Executives

  • Mark Doerr
    President, Chief Executive Officer & Director
  • Ramona Seabaugh
    Chief Financial Officer
  • David John Rawlins
    Chief Commercial Officer
  • Bob McClune
    Senior Vice President-Data & Analytics
  • Will Misloski
    Chief Marketing Officer













MDVL Stock - Frequently Asked Questions

What is MedAvail's stock price forecast for 2023?

0 brokers have issued 12 month target prices for MedAvail's stock. Their MDVL share price forecasts range from $1.00 to $5.00. On average, they anticipate the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 971.8% from the stock's current price.
View analysts price targets for MDVL
or view top-rated stocks among Wall Street analysts.

How have MDVL shares performed in 2023?

MedAvail's stock was trading at $0.2998 on January 1st, 2023. Since then, MDVL shares have decreased by 6.6% and is now trading at $0.2799.
View the best growth stocks for 2023 here
.

Are investors shorting MedAvail?

MedAvail saw a increase in short interest in May. As of May 15th, there was short interest totaling 283,300 shares, an increase of 31.0% from the April 30th total of 216,200 shares. Based on an average trading volume of 111,500 shares, the short-interest ratio is currently 2.5 days.
View MedAvail's Short Interest
.

When is MedAvail's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our MDVL earnings forecast
.

How were MedAvail's earnings last quarter?

MedAvail Holdings, Inc. (NASDAQ:MDVL) announced its quarterly earnings data on Monday, November, 8th. The company reported ($0.34) EPS for the quarter, missing analysts' consensus estimates of ($0.32) by $0.02. The company earned $5.79 million during the quarter. MedAvail had a negative net margin of 150.00% and a negative trailing twelve-month return on equity of 211.71%. During the same period in the prior year, the business posted ($0.84) earnings per share.

What is MedAvail's stock symbol?

MedAvail trades on the NASDAQ under the ticker symbol "MDVL."

How do I buy shares of MedAvail?

Shares of MDVL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MedAvail's stock price today?

One share of MDVL stock can currently be purchased for approximately $0.28.

How much money does MedAvail make?

MedAvail (NASDAQ:MDVL) has a market capitalization of $22.54 million and generates $43.11 million in revenue each year. The company earns $-47,620,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis.

How many employees does MedAvail have?

The company employs 287 workers across the globe.

How can I contact MedAvail?

MedAvail's mailing address is 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ, 07927. The official website for the company is www.medavail.com. The company can be reached via phone at (905) 812-0023, via email at jgoodford@myoscorp.com, or via fax at 973-348-5707.

This page (NASDAQ:MDVL) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -